These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 18332066

  • 1. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [Abstract] [Full Text] [Related]

  • 2. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J, Meng XQ, Yang MF, Zhou L, Chen XM, Hu MJ, Fan WW, Ma WH, Li LJ.
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
    Christmas SE, Halliday D, Lawton N, Wang H, Abdalla I, Masters J, Hassan RL, Hart IJ, Khan N, Smith J, Hammad A, Bakran A.
    Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
    [Abstract] [Full Text] [Related]

  • 4. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH, Mao YY, He Q, Wu JY, Lv R.
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [Abstract] [Full Text] [Related]

  • 5. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K, Sandhu S, Wu C, Muirhead N, Hollomby D, Jevnikar A.
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
    Opelz G, Daniel V, Naujokat C, Döhler B.
    Transplantation; 2009 Oct 27; 88(8):962-7. PubMed ID: 19855238
    [Abstract] [Full Text] [Related]

  • 7. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T, Jindra P, Svecová M, Kormunda S, Opatrný K, Treska V.
    J Clin Virol; 2006 Jun 27; 36(2):146-51. PubMed ID: 16531113
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus infection in renal transplant recipients.
    Carstens J, Andersen HK, Spencer E, Madsen M.
    Transpl Infect Dis; 2006 Dec 27; 8(4):203-12. PubMed ID: 17116133
    [Abstract] [Full Text] [Related]

  • 9. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
    Taherimahmoudi M, Ahmadi H, Baradaran N, Montaser-Kouhsari L, Salem S, Mehrsai A, Kalantar E, Jahani Y, Pourmand G.
    Transplant Proc; 2009 Sep 27; 41(7):2841-4. PubMed ID: 19765452
    [Abstract] [Full Text] [Related]

  • 10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A, Serrano R, Gimeno A, de Juan J, Merino E, Jiménez del Cerro L, Olivares J.
    Nefrologia; 2007 Feb 20; 27(2):202-8. PubMed ID: 17564566
    [Abstract] [Full Text] [Related]

  • 12. The effect of cytomegalovirus antigenemia titer on the efficacy of preemptive therapy for the prevention of cytomegalovirus disease after kidney transplantation.
    Jung GO, Kim SJ, Choi GS, Moon JI, Kim JM, Sin MJ, Kim EY, Kwon CH, Joh JW, Lee SK.
    Transplant Proc; 2010 Apr 20; 42(3):804-10. PubMed ID: 20430177
    [Abstract] [Full Text] [Related]

  • 13. Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation.
    Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A.
    Nephrol Dial Transplant; 2008 Dec 20; 23(12):4054-60. PubMed ID: 18577532
    [Abstract] [Full Text] [Related]

  • 14. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B, Vester U, Wingen AM, Nadalin S, Paul A, Broelsch CE, Hoyer PF.
    Pediatr Transplant; 2008 Jun 20; 12(4):474-8. PubMed ID: 18466436
    [Abstract] [Full Text] [Related]

  • 15. Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?
    Essa S, Pacsa A, Said T, Nampoory MR, Raghupathy R, Johny KV, Al-Nakib W, Al-Mosawy M.
    Med Princ Pract; 2008 Jun 20; 17(1):66-70. PubMed ID: 18059104
    [Abstract] [Full Text] [Related]

  • 16. Detection of human leukocyte antigen compatibility and antibodies in liver transplantation in China.
    Meng XQ, Zhang X, Fan J, Zhou L, Hao B, Chen XM, Ma WH, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2009 Apr 20; 8(2):141-5. PubMed ID: 19357026
    [Abstract] [Full Text] [Related]

  • 17. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
    Kekik C, Besisik SK, Seyhun Y, Oguz FS, Sargin D, Carin MN.
    Transplant Proc; 2009 Nov 20; 41(9):3859-62. PubMed ID: 19917401
    [Abstract] [Full Text] [Related]

  • 18. 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.
    Doyle AM, Warburton KM, Goral S, Blumberg E, Grossman RA, Bloom RD.
    Transplantation; 2006 Apr 27; 81(8):1106-11. PubMed ID: 16641594
    [Abstract] [Full Text] [Related]

  • 19. Cytomegalovirus antibody status and kidney transplantation.
    Terasaki PI, Yuge J, Cecka JM, Gjertson DW.
    Clin Transpl; 1994 Apr 27; ():509-18. PubMed ID: 7547579
    [Abstract] [Full Text] [Related]

  • 20. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
    Jin ZK, Xu CX, Tian PX, Xue WJ, Ding XM, Zheng J, Ding CG, Ge GQ, Mao TC, Lin Y.
    Transpl Immunol; 2012 Oct 27; 27(2-3):69-74. PubMed ID: 22750489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.